Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 115 of the 116 references it cites were found in a registry or an index.

The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases

Open access

Abstract

Cellular senescence represents a robust tumor-protecting mechanism that halts the proliferation of stressed or premalignant cells. However, this state of stable proliferative arrest is accompanied by the Senescence-Associated Secretory Phenotype (SASP), which entails the copious secretion of proinflammatory signals in the tissue microenvironment and contributes to age-related conditions, including, paradoxically, cancer. Novel therapeutic strategies aim at eliminating senescent cells with the use of senolytics or abolishing the SASP without killing the senescent cell with the use of the so-called “senomorphics”. In addition, recent works demonstrate the possibility of modifying the composition of the secretome by genetic or pharmacological intervention. The purpose is not to renounce the potent immunostimulatory nature of SASP, but rather learning to modulate it for combating cancer and other age-related diseases. This review describes the main molecular mechanisms regulating the SASP and reports the evidence of the feasibility of abrogating or modulating the SASP, discussing the possible implications of both strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biology9120485

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Therapeutic approaches of Senescence-Associated Secretory Phenotype (SASP) modulation (A) SASP modulation could synergize with therapy-induced senescence (TIS), abrogating the pro-tumorigenic properties of SASP while preserving or even boosting the anti-tumor immune response; (B) the use of senomorphics in age-related disorders could abolish the chronic and sterile inflammation that causes tissue disfunction. Abbreviations: SASP: Senescence-associated secretory phenotype; OIS: Oncogene-induced senescence; TIS: Therapy-induced senescence; GFs: Growth factors; MMPs: Matrix metalloproteinases.
Figure 1 Therapeutic approaches of Senescence-Associated Secretory Phenotype (SASP) modulation (A) SASP modulation could synergize with therapy-induced senescence (TIS), abrogating the pro-tumorigenic properties of SASP while preserving or even boosting the anti-tumor immune response; (B) the use of senomorphics in age-related disorders could abolish the chronic and sterile inflammation that causes tissue disfunction. Abbreviations: SASP: Senescence-associated secretory phenotype; OIS: Oncogene-induced senescence; TIS: Therapy-induced senescence; GFs: Growth factors; MMPs: Matrix metalloproteinases.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 116 references

Cited by

See all 308

Metadata

Authors
Cuollo, L., Antonangeli, F., Santoni, A., & Soriani, A.
Affiliations
  • Italian Institute of Technology (IT)
  • Institute of Molecular Biology and Pathology (IT)
  • Istituto Neurologico Mediterraneo (IT)
  • Istituto Pasteur (IT)
Corresponding author
Soriani, Alessandra
Venue
Biology
Publisher
MDPI AG
Published
2020-12-21
Volume
9
Issue
12
Pages
485
ISSN
2079-7737 (ISSN-L)
OpenAlex
W3116631834
Cited by
291
References
116
Citations by year
2026: 41 · 2025: 68 · 2024: 55 · 2023: 65 · 2022: 40 · 2021: 22
FWCI
4.04
Type
journal article
Language
en
Open access
Locations
  • Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • AIRC 5x1000 (21147)
  • Progetto di Ricerca 2019 – Sapienza University of Rome (RP11916B79E083FC.)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Keywords
senescence-associated secretory phenotype, cellular senescence, senolytics, senomorphics, senolytic therapy, senescence-associated secretome, tumor microenvironment, inflammatory cytokines, age-related diseases, cancer therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases. https://app.cochat.ai/papers/10.3390/biology9120485
The paper
Cuollo, L., Antonangeli, F., Santoni, A., & Soriani, A. (2020). The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases. Biology. https://doi.org/10.3390/biology9120485

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.